These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28810157)

  • 1. Propagating the Haze? Community and professional perceptions of cannabis cultivation and the impacts of prohibition.
    Beckett Wilson H; Taylor S; Barrett G; Jamieson J; Grindrod L
    Int J Drug Policy; 2017 Oct; 48():72-80. PubMed ID: 28810157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model.
    Lenton S; Frank VA; Barratt MJ; Dahl HV; Potter GR
    Int J Drug Policy; 2015 Mar; 26(3):257-66. PubMed ID: 25181993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "The difference is in the tomato at the end": Understanding the motivations and practices of cannabis growers operating within Belgian Cannabis Social Clubs.
    Pardal M
    Int J Drug Policy; 2018 Jun; 56():21-29. PubMed ID: 29539581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the harms of cannabis cultivation in Belgium.
    Paoli L; Decorte T; Kersten L
    Int J Drug Policy; 2015 Mar; 26(3):277-89. PubMed ID: 25599596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production, perceptions, and punishment: restrictive deterrence in the context of cannabis cultivation.
    Nguyen H; Malm A; Bouchard M
    Int J Drug Policy; 2015 Mar; 26(3):267-76. PubMed ID: 25223245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global patterns of domestic cannabis cultivation: sample characteristics and patterns of growing across eleven countries.
    Potter GR; Barratt MJ; Malm A; Bouchard M; Blok T; Christensen AS; Decorte T; Frank VA; Hakkarainen P; Klein A; Lenton S; Perälä J; Werse B; Wouters M
    Int J Drug Policy; 2015 Mar; 26(3):226-37. PubMed ID: 25582281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The three betrayals of the medical cannabis growing activist: From multiple victimhood to reconstruction, redemption and activism.
    Klein A; Potter GR
    Int J Drug Policy; 2018 Mar; 53():65-72. PubMed ID: 29287224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges.
    Davenport S; Pardo B
    Int J Drug Policy; 2016 Nov; 37():60-69. PubMed ID: 27596698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Should I Buy or Should I Grow?" How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic.
    Belackova V; Maalsté N; Zabransky T; Grund JP
    Int J Drug Policy; 2015 Mar; 26(3):296-310. PubMed ID: 25655217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating alternative cannabis regimes.
    MacCoun R; Reuter P
    Br J Psychiatry; 2001 Feb; 178():123-8. PubMed ID: 11157425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis social clubs in Belgium: organizational strengths and weaknesses, and threats to the model.
    Decorte T
    Int J Drug Policy; 2015 Feb; 26(2):122-30. PubMed ID: 25179934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growing medicine: small-scale cannabis cultivation for medical purposes in six different countries.
    Hakkarainen P; Frank VA; Barratt MJ; Dahl HV; Decorte T; Karjalainen K; Lenton S; Potter G; Werse B
    Int J Drug Policy; 2015 Mar; 26(3):250-6. PubMed ID: 25123694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis policies and user practices: market separation, price, potency, and accessibility in Amsterdam and San Francisco.
    Reinarman C
    Int J Drug Policy; 2009 Jan; 20(1):28-37. PubMed ID: 18367390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based policy? The re-medicalization of cannabis and the role of expert committees in the UK, 1972-1982.
    Taylor SL
    Int J Drug Policy; 2016 Nov; 37():129-135. PubMed ID: 27477790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from conducting trans-national Internet-mediated participatory research with hidden populations of cannabis cultivators.
    Barratt MJ; Potter GR; Wouters M; Wilkins C; Werse B; Perälä J; Pedersen MM; Nguyen H; Malm A; Lenton S; Korf D; Klein A; Heyde J; Hakkarainen P; Frank VA; Decorte T; Bouchard M; Blok T
    Int J Drug Policy; 2015 Mar; 26(3):238-49. PubMed ID: 25576247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenges in developing a rational cannabis policy.
    Hall W; Lynskey M
    Curr Opin Psychiatry; 2009 May; 22(3):258-62. PubMed ID: 19293714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making residential cannabis growing operations actionable: a critical policy analysis.
    Carter C
    Int J Drug Policy; 2009 Jul; 20(4):371-6. PubMed ID: 19111455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy.
    Werb D; Nosyk B; Kerr T; Fischer B; Montaner J; Wood E
    Int J Drug Policy; 2012 Nov; 23(6):436-41. PubMed ID: 23085258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018.
    Cox C
    Health Policy; 2018 Mar; 122(3):205-209. PubMed ID: 29429644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC.
    Van Laar M; Van Der Pol P; Niesink R
    Int J Drug Policy; 2016 Aug; 34():58-64. PubMed ID: 27471078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.